Inozyme Pharma Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701

February 16, 2023

https://www.globenewswire.com/news-release/2023/02/16/2609610/0/en/Inozyme-Pharma-Reports-Positive-Topline-Data-from-Ongoing-Phase-1-2-Trials-of-INZ-701.html

– Rapid, significant, and sustained increase in plasma pyrophosphate (PPi) observed and encouraging patient reported outcome data in all dose cohorts in ENPP1 Deficiency trial –

Read more at globenewswire.com

Related news for (INZY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.